Q3 2019 Investor Presentation slide image

Q3 2019 Investor Presentation

> COPD is a large and growing market . . . COPD is the third leading cause of death worldwide 1 More than 380 million people worldwide are estimated to have COPD 2 - Largely undiagnosed COPD sufferers in high-growth markets such as China, India, Brazil and E. Europe may be well over 100 million 3 • Cost to healthcare systems from COPD is enormous: - Europe: ~€48 billion per year - US: ~$50 billion per year5 • More than 3 million people worldwide die each year due to COPD 6 1World Health Organization. The top 10 causes of death: Fact sheet: No310 (2014, May) accessed 20 Jul16 2 https://www.ncbi.nlm.nih.gov/pubmed/26755942 3 Company estimates based on World Health Organization estimates and Zhong et al. "Prevalence of Chronic Obstructive Pulmonary Disease in China" Respiratory and Critical Care 4 European Respiratory Society, European Lung White Book http://www.erswhite book.org/chapters/the-economic-burden-of-lung-disease/ accessed 20Jul16 5 Guarascio et al. Dove Med Press, 2013 Jun 17 6 World Health Organization. Chronic obstructive pulmonary disease (COPD): Fact sheet No315. 2015 accessed 20 Jul16 © 2019 ResMed I Q3 2019 Investor Presentation | 19 ResMed
View entire presentation